Design Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.194; its P/E ratio is -3.26; Design Therapeutics is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -15.79M	$ -19.94M	$ -19.29M	$ -17.34M	$ -19.19M
EBITDA	-	$ -21.19M	$ -20.30M	$ -18.10M	$ -19.08M
Net Income Common Stockholders	$ -15.79M	$ -19.94M	$ -19.29M	$ -17.34M	$ -17.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 290.94M	$ 303.09M	$ 315.39M	$ 330.39M	$ 344.23M
Total Assets	$ 299.87M	$ 311.63M	$ 322.84M	$ 341.14M	$ 354.57M
Total Debt	$ 2.52M	$ 2.70M	$ 2.88M	$ 3.05M	$ 3.84M
Net Debt	$ -288.42M	$ -300.39M	$ -312.51M	$ -327.34M	$ -340.39M
Total Liabilities	$ 14.91M	$ 14.84M	$ 11.93M	$ 13.83M	$ 13.63M
Stockholders Equity	$ 284.96M	$ 296.79M	$ 312.78M	$ 327.31M	$ 340.94M
Cash Flow	-
Free Cash Flow	-	$ -13.89M	$ -17.51M	$ -15.38M	$ -14.21M
Operating Cash Flow	$ -14.53M	$ -13.80M	$ -17.42M	$ -15.09M	$ -13.90M
Investing Cash Flow	$ 15.27M	$ 11.98M	$ 19.73M	$ -1.06M	$ -63.39M
Financing Cash Flow	$ 13.00K	$ 210.00K	-	$ 130.00K	$ 151.00K

Currency in USD

Design Therapeutics Earnings and Revenue History

Income Statement >

Design Therapeutics Debt to Assets

Balance Sheet >

Design Therapeutics Cash Flow

Cash Flow >

Design Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing